baber/WOPTO huggingface dataset:
Patent MX-2020013427-A (MX)
Title: Inhibiting viral infection using alternating electric fields.
Inventor: GILADI MOSHE
IPC: A61N1/40
Filed: 2019-07-09
Abstract: Viral infections in a target region can be inhibited by imposing an alternating electric field in the target region for a duration of time. The alternating electric field has a frequency and a field strength such that when the alternating electric field is imposed in the target region for the duration of time, the alternating electric field inhibits infection of the cells in the target region by the virus. Optionally, the inhibition of viral infections using the alternating electric field approach can be combined with delivering an antiviral agent to the target region so that a therapeutically effective dose of the antiviral agent is present in the target region while the alternating electric fields are imposed.
Patent MX-2021000410-A (MX)
Title: Verbascoside and related compounds for sweetness enhancement.
Inventor: CHIN Hsi- Wen
IPC: A23L27/00
Filed: 2019-07-12
Abstract: The use of verbascoside or a related compound thereof to enhance the sweetness of a sweetness modifier and to decrease the amount of a sweetness modifier used in a consumable is provided.
Patent MX-2021004792-A (MX)
Title: Seed treater.
Inventor: BREWER DAMIEN DOUGLAS
IPC: A01C1/00
Filed: 2019-11-01
Abstract: A seed treater having upper and lower ends includes a mixing bowl. The mixing bowl includes a stator having an annular upper inner surface defining an upper portion of the open interior of the mixing bowl, and a rotor defining a lower portion of the open interior of the mixing bowl. An air duct is fluidly connected to the mixing bowl and is configured to be fluidly connected to an air mover. The air duct includes a duct outlet configured to direct forced air from the air mover into the upper portion of the open interior defined by the upper stator to direct the seeds flowing in the upper portion of the interior of the mixing bowl inward toward a generally vertical axis of the mixing bowl as the lower rotor rotates relative to the upper stator.
Patent MX-2021008976-A (MX)
Title: Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer.
Inventor: BENESOVA MARTINA
IPC: C07B59/00
Filed: 2016-04-18
Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (la) or (lb).
Patent MX-2021010297-A (MX)
Title: Human plasma kallikrein inhibitors.
Inventor: KOTIAN PRAVIN L
IPC: A61K31/40
Filed: 2018-03-28
Abstract: Disclosed are compounds of formula I, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also provided are pharmaceutical compositions comprising at least one compound of the invention, and methods involving use of the compounds and compositions of the invention in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity.
Patent MX-2021010317-A (MX)
Title: Amine composition useful for making stable polyurethane foam systems.
Inventor: BURDENIUC JUAN JESUS
IPC: C07C211/14
Filed: 2020-02-27
Abstract: Acatalyst composition comprising at least one compound with a general formula (I) wherein A is N-R<sup>3</sup>, R<sup>3</sup> is C<sup>1</sup>-C<sup>8</sup> linear or branched, x = 0-6, n and m are each independently 1 to 6, R1 and R2 are each independently C<sub>2</sub> -C<sub>8</sub> alkyl, and R<sup>4</sup> and R<sup>5</sup> are -CH<sub>3</sub> groups; or A = O, x = 0-6, n and m are each independently 1 to 6, R<sup>1</sup> and R <sup>2</sup> are each independently C<sub>2</sub>-C<sub>8</sub> alkyl, and R<sup>4</sup> and R<sup>5</sup> are -CH<sub>3</sub> groups; or A = O or N-R<sup>3</sup>, R<sup>3</sup> is C<sub>1</sub>-C<sub>8</sub> linear or branched, and N(R<sup>1</sup>---R<sup>4</sup>) and N(R<sup>2</sup>---R<sup>5</sup>) each independently represent a C<sub>3</sub>-C<sub>7</sub> ring amine moiety of the type: (II).
Patent MX-2021010328-A (MX)
Title: Syringe with multifunctional needle holder and retainer ring assembly.
Inventor: SHAW THOMAS J
IPC: A61M5/00
Filed: 2019-09-19
Abstract: A syringe for medical use, the syringe having a selectively retractable needle and a multifunctional needle holder and retainer ring assembly including a needle holder with a head section having an inwardly tapering frustoconical section of the fluid pathway and a rearwardly facing annular surface surrounding the rear opening, and an elastomeric retainer ring with a substantially unexpanded collar extending rearwardly beyond the rearwardly facing annular surface to increase needle pushout force, reduce activation force and improve fluid flow through the syringe. Annular projections inside the retainer ring and on the outer surface of the head section of the needle holder are also disclosed.
Patent MX-2021010397-A (MX)
Title: A soap bar with improved perfume impact and deposition of actives.
Inventor: AGARKHED AJIT MANOHAR
IPC: C11D9/00
Filed: 2020-02-24
Abstract: The present invention relates to an extruded bar soap composition. It more particularly relates to a soap bar composition which exhibits better bloom (perfume impact) and better deposition of actives as compared to conventional soap bars. This is obtained by ensuring that the amount of oleate soap is kept low while incorporating some amount of ricinoleate soap.
Patent MX-2021011008-A (MX)
Title: Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor.
Inventor: LI YONG
IPC: C07D215/54
Filed: 2020-02-07
Abstract: The present invention relates to fused piperidinyl bicyclic, meta-substituted piperidinyl and their related compounds that modulate activities of mammalian C5a receptor by directly binding to the C5a receptor. The invention also relates to pharmaceutical compositions containing such compounds and their use in the treatment of a disease or a disorder involving pathogenic activation of C5a receptors.
Patent MX-2021011142-A (MX)
Title: Storage system.
Inventor: VAN DER VELDEN SILVESTER HELENA GERARDUS ROLAND
IPC: B25J19/02
Filed: 2021-09-13
Abstract: Storage system, comprising a plurality of shelving units that are each driveably movable in a width direction wherein the storage system further comprises a safety system for determining whether movement is permitted, wherein the safety system comprises at least one camera, configured to provide an image of an interspace between a first shelving unit and a second shelving unit adjacent to the first shelving unit and a control device, for controlling the movement of the shelving units, and for executing a command if the first and second camera images show more than a predetermined amount of correspondence and ignoring the command if the first and the second camera images show more than a predetermined amount of deviation.
Patent MX-2021012214-A (MX)
Title: Electrodialysis systems with decreased concentration gradients at high recovery rates.
Inventor: DEMETER ETHAN
IPC: C02F1/469
Filed: 2020-04-09
Abstract: Provided are electrodialysis systems comprising a plurality of electrodialysis devices, wherein each electrodialysis device of the plurality of electrodialysis devices has a product inlet stream, a product outlet stream, a brine inlet stream, and a brine outlet stream. The product inlet stream for a first electrodialysis device comprises the brine outlet stream of a second electrodialysis device. Further, a first portion of a feed stream is the brine inlet stream for the first electrodialysis device and a second portion of the feed stream is the brine inlet stream for the second electrodialysis device or a third electrodialysis device.
Patent MX-2021013392-A (MX)
Title: Multiplexing control information in a physical uplink data channel.
Inventor: PAPASAKELLARIOU ARIS
IPC: H04L1/00
Filed: 2019-06-07
Abstract: Methods and apparatuses for multiplexing control information in a physical uplink data channel. A method of a user equipment (UE) includes receiving a configuration for a first set of values and receiving a downlink control information (DCI) format scheduling a transmission of a physical uplink shared data channel (PUSCH) over a set of resource elements (REs) and including a field providing an index. The method further includes determining a first value from the first set of values based on the index, determining a first subset of REs from the set of REs, for multiplexing first uplink control information (UCI), based on the first value, and transmitting the first UCI in the PUSCH.
Patent MX-2021013521-A (MX)
Title: Matrix-based intra prediction.
Inventor: HINZ TOBIAS
IPC: H04N19/423
Filed: 2020-05-11
Abstract: Apparatus for predicting a predetermined block (18) of a picture using a plurality of reference samples (17a, c) The apparatus is configured to form (100) a sample value vector (102, 400) out of the plurality of reference samples, derive from the sample value vector a further vector onto which the sample value vector is mapped by a predetermined invertible linear transform, compute a matrix-vector product between the further vector and a predetermined prediction matrix so as to obtain a prediction vector, and predict samples of the predetermined block on the basis of the prediction vector.
Patent MX-2021014448-A (MX)
Title: Modulation of stimulatory and non-stimulatory myeloid cells.
Inventor: KRUMMEL MATTHEW
IPC: A61K39/395
Filed: 2017-03-27
Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
Patent MX-2021014874-A (MX)
Title: Cooling cap assembly and cooling unit.
Inventor: DILLIGAN KATHLEEN
IPC: A61F7/00
Filed: 2020-06-03
Abstract: Devices, systems, and methods herein relate to cooling a head of a patient. These systems and methods may comprise a cooling cap assembly comprising a heat exchanger configured to be wrapped around a head of a patient and a compression assembly releasably coupled to the heat exchanger. The compression assembly may comprise an enclosure and an inflatable member coupled to an internal surface of the enclosure. When coupled, the inflatable member may be positioned between the enclosure and the heat exchanger. The heat exchanger may be separate from and moveable relative to the inflatable member.
Patent MX-2022000133-A (MX)
Title: Anti-cd154 antibodies and uses thereof.
Inventor: LEDERMAN SETH
IPC: A61K39/00
Filed: 2020-07-01
Abstract: This disclosure relates to anti-human CD154 antibodies with modified effector function. This disclosure also relates to the use of these anti-human CD154 antibodies in treating conditions associated with CD154 activation, such as transplant rejection, inflammatory conditions and disease, dysfunctional immune responses associated with viral infections and diseases, autoimmune conditions and disease, allergic conditions, atherosclerotic conditions, or neurodegenerative conditions and diseases. It also relates to the use of these anti-human CD154 antibodies in inducing central tolerance and hematopoietic chimerism in transplant patients.
Patent MX-2022007633-A (MX)
Title: Levering structure for a ceramic cutter device.
Inventor: GUARDIA CARLOS MANOEL
IPC: B28D1/22
Filed: 2020-12-01
Abstract: A levering structure for a ceramic cutter device comprising a main body assembly (2) and an actuator element (6). The main body assembly (2) comprises a first (28) and a second (18) body structure, both being pivotably connected to each other by means of a first articulation, so that a first and a second pivoting end positions are defined. The actuator element is pivotably connected to the first body structure, and comprises curvilinear base in contact with a contact pivot shaft transversally arranged on the second body structure, the curvilinear base defining a first and a second leverage positions. The levering structure is configured such that when the first body structure (28) is pivoted from the first to the second pivoting end position, the pivoting movement of the first body structure (28) causes the actuator element (6) to move from the first leverage position to the second leverage position.
Patent MX-2022010732-A (MX)
Title: Alk4:actriib heteromultimers and uses thereof.
Inventor: PEARSALL ROBERT SCOTT
IPC: C07K14/71
Filed: 2017-10-05
Abstract: In certain aspects, the disclosure provides soluble heteromeric polypeptide complexes comprising an extracellular domain of an ALK4 receptor and an extracellular domain of ActRIIB. In certain aspects, such soluble ALK4: ActRIIB complexes may be used to regulate (promote or inhibit) growth of tissues or cells including, for example, muscle, bone, cartilage, fat, neural tissue, tumors, and/or cancerous cells. In certain aspects, such ALK4: ActRIIB complexes are can be used to improve muscle formation, bone formation, metabolic parameters, and disorders associated with these tissues, cellular networks, kidney, and endocrine systems.
Patent MX-2022016494-A (MX)
Title: Anti-il13rî±2 antibodies.
Inventor: VAN BERKEL PATRICIUS HENDRIKUS CORNELIS
IPC: C07K16/28
Filed: 2021-07-30
Abstract: This disclosure relates to antibodies that specifically bind to the Interleukin-13 receptor subunit alpha- 2 (IL13RÎ±2) protein, and associated uses and methods for production.
Patent MX-NL02000035-A (MX)
Title: Transformer generator of magnetic resonance into electric energy.
Inventor: DONALD LEE SMITH
Filed: 2002-11-15
Abstract: The present invention refers to an electric-energy generator transformer by electromagnetic means through a potential generator and the employment of capacitor or condenser plates (or bobbins) a receptor component of magnetic energy which is transformed into electric current. Giving as a result that the induction current component is transformed into useful electric energy.
Patent MX-PA00004926-A (MX)
Title: Superabsorbient gels based on poly (dialquilaminoalquil (met) acrilami
Inventor: BEIHOFFER THOMAS W
IPC: A61F13/49
Filed: 2000-05-19
Abstract: Super-absorbent gels based on poly (dialkylaminoalkyl (meth) acrylamide) are deviated. The superabsorbent gels comprise a mixture of poly (dialkylaminoalkyl (meth) acrylamide) polymer and a water-absorbing polymeric acid, such as polyacrylic acid, or comprises a salt of a poly (dialkylaminoalkyl (meth) acrylamide) polymer. An improved method for preparing an N- (dialkylaminoalkyl (meth) acrylamide monomer is also described.
Patent MX-PA00005954-A (MX)
Title: Proteins for cancer cell specific induction of apoptosis andmethod for isolation thereof.
Inventor: DAVID TSAI
IPC: C07K14/47
Filed: 1998-12-18
Abstract: The present invention provides the methods to isolate the proteins specifically induced apoptosis (programmed cell death) in prostate cancer cells (LNCAP), leukemia cells (HL-60), and breast cancer cells (MCF-70), but without effect in normal human lung fibroblast cells (CCD 39 Lu). P-1 has no effect on breast cancer cells. Five proteins have been isolated from the conditioned media of culture cells: (1) Apogen P-1: the proteins (Apogen P-1a, Apogen P-1b and Apogen P-1c) isolated from the conditioned medium of XC cells are able to induce apoptosis in prostate cancer cells (LNCAP) without effect in normal human lung fibroblast (CCD 39 Lu), colon cancer (T84), breast cancer (MCF-7) and leukemia (HL-60) cells. (2) Apogen P-2: the protein isolated from the conditioned medium of C3H1OT1/2 cells is able to induce apoptosis in prostate cancer cells (LNCAP) and breast cancer (MCF-7) without effect in normal human lung fibroblast (CCD 39 Lu) and colon cancer (T84) cells. (3) Apogen L: the protein isolated from the conditioned medium of XC cells is able to induce apoptosis in leukemia cells (HL-60), and breast cancer (MCF-7) without effect in normal human lung fibroblast (CCD 39 Lu), colon cancer (T84) and prostate cancer (LNCAP) cells. The invention may lead to the discovery of a novel class of anticancer drug that aims at prostate cancer, breast cancer, leukemia and other cancers by inducing apoptosis in cancer cells without affecting normal cells.
Patent MX-PA00011095-A (MX)
Title: Digital hidden data transport (dhdt).
Inventor: LEE CHONG U
IPC: H04B1/707
Filed: 1999-04-20
Abstract: A system for embedding auxiliary digital information (Di) into an existing primary digitally encoded signal (Xn) to form an unobjectionable composite digital signal (Cn). Auxiliary data bits (Di) modulate a pseudo-random (e.g., PN) sequence (125) to provide an auxiliary data sequence (160) that is used to modify the Least Perceptually Significant Bits (LPSBs) (180) of successive multi-bit samples (120) of the primary signal. In a cross-term compensation embodiment (300, 400, 1000), a correlation (V) between the PN sequence and the sample bits is determined, and compared to the auxiliary data bits (Di) to determine whether there is a desired correspondence. The LPSBs in the samples are toggled (360), if necessary, to provide the desired correspondence. The selection of LPSBs to modify accounts for a desired noise level of the auxiliary data (Di) in the primary signal (Xn). LPSBs may be selected to be modified based on a sparse PN sequence (250) to achieve the desired noise level and to conceal the presence of the auxiliary data (Di). The data to be hidden can be any digital data, while the primary signal is any uncompressed or compressed digitally sampled process, including, for example, audio or video data.
Patent MX-PA01002633-A (MX)
Title: Resilient support for erectable shelter roof.
Inventor: CARTER MARK C
IPC: E04H15/50
Filed: 1999-08-12
Abstract: The erectable shelter (10) includes a truss framework that provides an elevated, raised canopy (12) that can have a high peak in a raised, extended configuration. The shelter (10) includes a canopy (12), a leg assembly (18), and a perimeter truss linkage assembly (40) having a plurality of perimeter truss pairs (42) of link members connected to the leg assembly (18). The legs (18) preferably have telescoping upper and lower sections (20, 22) with lower section (22) for engagement with ground, and a slider member (32) slidably mounted to the upper section (20) of each of the legs (18). A canopy peak support assembly (150) is provided that is movable between a raised position and a lowered position, with the canopy peak support assembly (150) supporting the canopy (12) above the top of the leg assembly (18) in the raised position. The canopy peak support assembly (150) includes a flexible center support member (130) such as a rubber tube or spring coil that can bend in response to the force of strong winds.
Patent MX-PA01005160-A (MX)
Title: Method for oscillating a continuous-casting mould by means of variable oscillation parameters.
Inventor: VONDERBANK MICHAEL
IPC: B22D11/053
Filed: 1999-11-17
Abstract: The invention relates to a method for oscillating a continuous-casting mould by means of vertically alternating movements in or against the direction of casting, the stroke and frequency of the oscillation being parameters which can be set in accordance with casting speed. If the mould presents a forward slip in relation to the strand, that is the so-called negative strip, liquid and/or solid casting material is drawn into the gap between mould and strand. By uncoupling the linear relation between casting speed and the oscillation parameters stroke/frequency the parameters are varied insofar as with increasing casting speed acceleration of the moving system is reduced overall by way of a relative decrease in frequency and relative increase in stroke.
Patent MX-PA01005438-A (MX)
Title: Enzymatic oxidations.
Inventor: MICHAEL STEPHEN PACEY
IPC: C07D405/04
Filed: 2001-05-30
Abstract: The following invention relates to a process for oxidising alkyl groups attached directly or via a linker, to a sulfonamide moiety (II) by the use of cytochrome P450 enzymes, to give the corresponding alcohol or carboxylic acid (I). Wherein R is an organic radical, X is a linker, Y is -C (CH3)2- or -CH(CH3)- and Z is -CH2OH or -COOH.
Patent MX-PA01006998-A (MX)
Title: Use of apoptosis inducing agents in the treatment of (auto)immune diseases.
Inventor: NOTEBORN MATHIEU HUBERTUS MARI
IPC: A61K45/00
Filed: 2000-01-10
Abstract: The invention relates to therapies for (auto)immune diseases. Synthesis or presence of apoptotic activity in cells causing or related to (auto)immune diseases, such as synoviocytes in rheumatoid arthritis, will result in the induction of apoptosis. The invention also relates to gene-delivery vehicles, which comprise nucleic acid molecules encoding apoptosis-inducing proteins with apoptin-like activity.
Patent MX-PA01007451-A (MX)
Title: Substituted porphyrins.
Inventor: CRAPO JAMES D
IPC: A61P39/06
Filed: 2000-01-25
Abstract: The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
Patent MX-PA01007792-A (MX)
Title: Alkyl amino acid derivatives useful as pharmaceutical agents.
Inventor: JUSTIN STEPHEN BRYANS
IPC: A61P25/24
Filed: 2001-08-01
Abstract: GABA-related pro-drugs of the formula (III) are provided that when administered to humans or other mammals provide an increased duration of active compound in the plasma compared to compounds of corresponding structure in which labile groups are not present. The compounds are of the formula (III) <EMI ID=1.1 HE=30 WI=50 LX=837 LY=1107 TI=CF> In the above formula: ```P represents hydrogen or methyl; ```Q represents a labile amine- or amide-forming organic group that becomes removed in the human or animal body; ```R<SP>1</SP> represents straight or branched C<SB>1</SB> - C<SB>6</SB> alkyl, C<SB>3</SB> - C<SB>6</SB> cycloalkyl or phenyl; ```R<SP>2</SP> represents hydrogen or methyl; and ```R<SP>3</SP> represents hydrogen, methyl or carboxyl; and ```R<SP>4</SP> represents hydrogen or a labile ester-forming group selected from substituted and unsubstituted C<SB>1</SB> - C<SB>6</SB> alkyl, benzyl and phenyl groups that become removed in the human or animal body. Pharmaceutically acceptable salts of any salt-forming compound within the above class are also included. The compounds may be used to treat a range of neurological conditions, e.g. epilepsy and pain.
Patent MX-PA01009564-A (MX)
Title: Synergistic insecticide mixtures.
Inventor: FISCHER REINER
IPC: A01N43/12
Filed: 2000-03-14
Abstract: The invention relates to insecticide mixtures containing compounds of formula (I) wherein X', Y', Z', n, G', A' and B' have the meanings given above and agonists or antagonists of nicotinergic acetylcholin receptors for protecting plants from pest infestation.
Patent MX-PA02004021-A (MX)
Title: A therapeutic mixture of hmg coa reductase inhibitors.
Inventor: WAYNE H KAESEMEYER
IPC: A61K31/22
Filed: 2000-10-19
Abstract: Therapeutic mixtures of statins alone or in combination with L arginine are described herein.